Alfavision Overseas (India) Limited (BOM:531156)
India · Delayed Price · Currency is INR 12.84
+0.25 (1.99%)
At close: Mar 27, 2026
BOM:531156 Market Cap
BOM:531156 has a market cap or net worth of 404.79 million as of March 27, 2026. Its market cap has decreased by -4.68% in one year.
Market Cap
404.79M
Enterprise Value
1.76B
Revenue
13.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.84
Market Cap Chart
Since October 21, 2004, BOM:531156's market cap has increased from 14.19M to 404.79M, an increase of 2,753.33%. That is a compound annual growth rate of 16.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 404.79M | 115.80% |
| Dec 31, 2025 | 187.58M | -57.19% |
| Dec 31, 2024 | 438.21M | -22.95% |
| Dec 29, 2023 | 568.73M | 43.63% |
| Dec 30, 2022 | 395.97M | 1.01% |
| Dec 31, 2021 | 392.03M | 328.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.22B |
| Kimia Biosciences | 1.20B |
| Tyche Industries | 1.07B |
| Resonance Specialties | 966.12M |
| Krebs Biochemicals & Industries | 940.69M |
| Bacil Pharma | 695.69M |
| Vasundhara Rasayans | 342.13M |
| Venmax Drugs and Pharmaceuticals | 300.00M |